Opening the door to hundreds of new drug candidates by directly accessing metabolites from uncultuable microorganisms consortia.
We have opened the door to a new frontier of fascinating compounds that could materially impact the direction of various chronic diseases. This is a massive market with urgency to license (revenue) novel, active, potent compounds. Biosortia has an internationally renowned leadership team along with superior value proposition with enormous competitive advantage and convincing early results. Biotech Drug Discovery Pharmaceutical Life Science